Quantcast

Latest Mammary ductal carcinoma Stories

2014-09-17 08:28:38

DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Breast Cancer Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer and...

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...

2014-07-01 16:26:24

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Breast Cancer Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/generic_drugs/global_breast_cancer_drugs_market.html About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal...

2014-06-11 08:29:34

Complete Data to be Submitted for Presentation at the 2014 San Antonio Breast Cancer Symposium REDWOOD CITY, Calif., June 11, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from a second large, independent clinical validation study of Oncotype DX® in patients with a pre-invasive form of breast cancer, also known as DCIS (ductal carcinoma in situ). The study, conducted by the Ontario DCIS Study Group in Canada, met its primary...

2014-06-04 15:29:19

Albert Einstein College of Medicine The study was led by researchers at the National Cancer Institute (NCI)─designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein Center for Cancer Care and was published online today in the Journal of the National Cancer Institute (JNCI). "Tests assessing metastatic risk can help doctors identify which patients should receive aggressive therapy and which patients should be spared,"...

2014-01-07 08:30:40

- Agreement to Distribute Oncotype DX(R) in Australia and New Zealand MELBOURNE, Australia, Jan. 7, 2014 /PRNewswire/ -- Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from chemotherapy, following an agreement between Specialised Therapeutics Australia (STA) and Genomic Health, Inc. (NASDAQ: GHDX). STA has struck an agreement to represent the important...

Mammography Screening Intervals May Affect Prognosis Of Breast Cancer
2013-12-04 12:07:52

Radiological Society of North America In a study of screening mammography-detected breast cancers, patients who had more frequent screening mammography had a significantly lower rate of lymph node positivity—or cancer cells in the lymph nodes—as compared to women who went longer intervals between screening mammography exams. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA). In its earliest stages, breast cancer is...

2013-10-11 23:19:21

Ductal carcinoma in situ (DCIS), a noninvasive breast cancer that some doctors are now arguing is over-treated, needs to be evaluated according to each woman’s risk, and more research is needed to better evaluate that risk, two Allegheny Health Network oncologists write in the Journal of the National Cancer Institute. DCIS represents up to 25% of new breast cancer diagnosis. Pittsburgh, PA (PRWEB) October 11, 2013 Ductal carcinoma in situ (DCIS), a noninvasive breast cancer that some...

2013-10-11 23:02:16

During Breast Cancer Awareness Month, The Breast Milagro is sharing information that younger women need to be alert to their risk and remain vigilant about breast health. Bellingham, WA (PRWEB) October 11, 2013 When Sylvia Bencomo of Albuquerque, NM, had her first mammogram at age 35, the radiologist noted an abnormality and recommended a follow-up exam. But six months later, when the mother of two young daughters requested a second mammogram, her concerns were brushed aside. She was told...

2013-09-18 15:45:20

Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). The incidence of DCIS has been increasing in the past decades, and this has been attributed to increased detection through breast cancer screening using mammograms. In the EORTC study, adjuvant radiotherapy after local excision reduced the incidence of both in situ and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.